Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,701 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system.
Katoh N, Soda I, Tamamura H, Takahashi S, Uchinami Y, Ishiyama H, Ota K, Inoue T, Onimaru R, Shibuya K, Hayakawa K, Shirato H. Katoh N, et al. Among authors: shibuya k. Radiat Oncol. 2017 Jan 5;12(1):3. doi: 10.1186/s13014-016-0742-3. Radiat Oncol. 2017. PMID: 28057036 Free PMC article.
Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame.
Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, Sakamoto M, Mitsumori M, Shibuya K, Araki N, Yano S, Hiraoka M. Nagata Y, et al. Among authors: shibuya k. Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1427-31. doi: 10.1016/j.ijrobp.2005.05.034. Epub 2005 Sep 19. Int J Radiat Oncol Biol Phys. 2005. PMID: 16169670 Clinical Trial.
Current status of stereotactic body radiotherapy for lung cancer.
Nagata Y, Matsuo Y, Takayama K, Norihisa Y, Mizowaki T, Mitsumori M, Shibuya K, Yano S, Narita Y, Hiraoka M. Nagata Y, et al. Among authors: shibuya k. Int J Clin Oncol. 2007 Feb;12(1):3-7. doi: 10.1007/s10147-006-0646-6. Epub 2007 Feb 25. Int J Clin Oncol. 2007. PMID: 17380434 Review.
[Radiation therapy for lung cancer].
Shibuya K, Hiraoka M. Shibuya K, et al. Gan To Kagaku Ryoho. 2007 Apr;34(4):544-9. Gan To Kagaku Ryoho. 2007. PMID: 17431339 Review. Japanese.
Patterns of radiotherapy practice for pancreatic cancer in Japan: results of the Japanese Radiation Oncology Study Group (JROSG) survey.
Ogawa K, Ito Y, Karasawa K, Ogawa Y, Onishi H, Kazumoto T, Shibuya K, Shibuya H, Okuno Y, Nishino S, Ogo E, Uchida N, Karasawa K, Nemoto K, Nishimura Y; JROSG Working Subgroup of Gastrointestinal Cancers. Ogawa K, et al. Among authors: shibuya k, shibuya h. Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):743-50. doi: 10.1016/j.ijrobp.2009.05.063. Epub 2009 Oct 29. Int J Radiat Oncol Biol Phys. 2010. PMID: 19879060
Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer.
Matsuo Y, Shibuya K, Nagata Y, Takayama K, Norihisa Y, Mizowaki T, Narabayashi M, Sakanaka K, Hiraoka M. Matsuo Y, et al. Among authors: shibuya k. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1104-11. doi: 10.1016/j.ijrobp.2009.12.022. Epub 2010 May 14. Int J Radiat Oncol Biol Phys. 2011. PMID: 20472343
1,701 results